This page is intended for reference during and after the NHS England AAA tender event taking place on 16th January 2025.

Saving Lives Through Advanced Ultrasound Technology: Mindray¡¯s Contribution to Scotland¡¯s AAA Screening Programme

Mindray is proud to play a vital role in Scotland¡¯s national screening programme aimed at the early detection of abdominal aortic aneurysms (AAA). Leveraging cutting-edge ultrasound technology, we have partnered with NHS Scotland to save lives by enabling timely diagnosis and preventative care.

?

Partnering for Better Health Outcomes

The Scottish AAA screening programme, implemented as part of the UK¡¯s "Four Nations" approach, is focused on identifying aneurysms in men aged 65 and above. When detected early, interventions can significantly reduce the risk of rupture, a condition that carries an 85% mortality rate. With 84% of eligible men attending screenings, the programme exemplifies the importance of accessible and accurate diagnostic tools.

Mindray¡¯s advanced M8 ultrasound systems were chosen exclusively for this initiative. Our devices¡ªrenowned for their portability, durability, and precision¡ªare pivotal in conducting high-quality scans across all 14 health boards in Scotland.

?

Unmatched Technology for Real-World Challenges

Dedicated Support for Seamless Implementation

To ensure a smooth rollout, Mindray deployed a dedicated team in Scotland, providing:

• Comprehensive training for healthcare professionals.
• On-site and virtual technical support.
• Ongoing collaboration to adapt our technology to evolving programme needs.

Making an Impact

Since its inception, the programme has conducted over 33,000 scans annually, recovering pre-pandemic participation levels and exceeding 95% patient satisfaction rates. This success underscores the transformative potential of combining innovative technology with dedicated healthcare initiatives.

Mindray is honoured to contribute to a programme that not only enhances diagnostic capabilities but also saves lives. Our commitment to delivering high-quality medical solutions remains unwavering, as we continue to empower healthcare providers worldwide.

References:

1. https://www.sehd.scot.nhs.uk/mels/cel2010_11.pdf

2.?https://publichealthscotland.scot/publications/scottishabdominal-aortic-aneurysm-aaascreening-programme-statistics/scottish-abdominal-aortic-aneurysm-aaascreening-programme-statistics-year-ending-31-march-2022/